- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Former Ambassador Nancy Brinker on the Future of the Susan G. Komen Foundation
Former Ambassador Nancy Brinker discusses the future of the Susan G. Komen Foundation stating, "It's time for major innovation."
Transcript
What do you see as the future of the Susan G. Komen Foundation?
What I think is is that the organization— every organization goes through major changes and rebuilding and new ideas and innovation. It's time for major innovation.
We have such strength in our affiliate communities who are really people on the ground that have learned so much. It's not so much what we do, it's how we do it that's going to be very important.
People are very sensitive to high overheads, they're very sensitive to anything spent. They want to see money that they give go directly to a mission. So, we're going to try very hard to make sure that we have collaborations with other people already doing the same thing, that we do things in a way— as we've always tried to do– as cost-effective as possible. Events become very expensive to do so we have to figure out other ways using technology to raise money and make sure that we connect with people.
[We also need to] get people of wealth in the country to understand that it's as important to fund a program as it is a building. In fact, sometimes the program goes farther to train people, to bring people in the system. So those are the sorts of things we'll work on.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More
